Neha R. Chawla, MD

Media Releases

Get to know Hematologist-Oncologist Dr. Neha R. Chawla, who serves patients in New Harbor Township, New Jersey.

Dr. Chawla is a determined hematologist-oncologist with a special interest in treating patients with breast cancer and lymphoma. She is in practice with AtlantiCare Health Park, Egg Harbor Township in New Jersey.

There, she works closely with physician colleagues in offering the full spectrum of community cancer care services—from evaluation and diagnosis to treatment, clinical trials, psychosocial support, wellness services, and survivorship care. 

Receiving her medical degree in India, Dr. Chawla graduated from Maulana Azad Medical College. She then relocated to the United States, performing her internship and residency in internal medicine at Rochester General Hospital. She also completed a fellowship in hematology and medical oncology at Thomas Jefferson University in Philadelphia.

Subsequent to her education, the doctor attained board certification in hematology and medical oncology through the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

In New Jersey, Dr. Chawla is affiliated with AtlantiCare Regional Medical Center, Atlantic City Campus & MD Anderson Cancer Center at Cooper – Egg Harbor Township.

Prior to her current endeavors, she was on faculty at Fox Chase Cancer Center as an adjunct professor in the Department of Hematology/Oncology.

Hematology is the branch of medicine concerned with the study of the cause, prognosis, treatment, and prevention of diseases related to blood. Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A hematologist-oncologist is a physician who specializes in the diagnosis, treatment, or prevention of cancer, malignant blood diseases such as leukemia, lymphoma, and multiple myeloma, and blood disorders such as iron-deficiency anemia, clotting abnormalities, hemophilia, and sickle-cell disease.

Recommended Articles

• Treatments for Multiple Myeloma

  The cancer care crew discusses what treatment will suit you after multiple myeloma has been diagnosed and staged. The following are treatments used in multiple myeloma:...

• Dreams Do Come True: 9-year-old Baseball Fanatic Signed Onto Team

  Like most young baseball fans, John “Parker” Staples' room is covered in memorabilia from his favorite team, the Washington Nationals, but unlike most kids, Parker's room is at the University of Virginia Children's Hospital.John “Parker” Staples, is nine-year old who was diagnosed with...

• Superheroes Unite For Elementary Student Fighting Lymphoma

  Anyone diagnosed with cancer knows how terrifying and debilitating the news can be. Now just imagine how horrible an experience it would be for an elementary school student to hear that they have cancer.It is a sad fact that thousands of children are diagnosed with cancer every year, and it is...

• Living as a Hodgkin Lymphoma Survivor: Creating a New Normal

  No one can ever truly be prepared for what it is like to live with cancer. Even the strongest survivors face setbacks, and some of the fiercest warriors share their stories of how they find their "new normals."Kimberly's storyWhen she was only 25, just five days before her wedding, Kimberly felt a...

• How Immunotherapy Makes a Real Difference in Relapsed Hodgkin Lymphoma

  Hodgkin lymphoma, which affects about 0.2% of the people in the United States, is often treated using a combination of chemotherapy, radiation therapy, and stem cell transplant. Sometimes these treatments fail to halt the progress of the disease, and in other cases the cancer seems to halt but then...

• Treatment Update for Hodgkin Lymphoma

  Over time, research has uncovered ways of treating Hodgkin lymphoma (HL) to produce an 80% to 90% cure rate. For the remaining 10% to 20% who are either resistant to the primary treatment or have relapsed, their cancer can still be fatal.The standard care for those not yet cured has been a two-step...